Cargando…

The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic Diseases

With the continuous improvement of living standards but the lack of exercise, aging-associated metabolic diseases such as obesity, type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD) are becoming a lingering dark cloud over society. Studies have found that metabolic disord...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Junbin, Nie, Yunmeng, Cao, Jielu, Luo, Minmin, Yan, Maoxiang, Chen, Zhiyun, He, Beihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044345/ https://www.ncbi.nlm.nih.gov/pubmed/33869312 http://dx.doi.org/10.3389/fcvm.2021.655575

Ejemplares similares

Exploring and Verifying the Mechanism and Targets of Shenqi Pill in the Treatment of Nonalcoholic Steatohepatitis via Network Pharmacology and Experiments
por: He, Beihui, et al.
Publicado: (2022)

Natural Compounds: A Potential Treatment for Alcoholic Liver Disease?
por: Yan, Junbin, et al.
Publicado: (2021)

Probiotics Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats via Gut Microbiota/FXR/FGF15 Signaling Pathway
por: Luo, Minmin, et al.
Publicado: (2021)

Multi-organ FGF21-FGFR1 signaling in metabolic health and disease
por: Kaur, Namrita, et al.
Publicado: (2022)

Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota
por: Yan, Junbin, et al.
Publicado: (2022)

Screening New Blood Indicators for Non-alcoholic Fatty Liver Disease (NAFLD) Diagnosis of Chinese Based on Machine Learning
por: Wang, Cheng, et al.
Publicado: (2022)

Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes
por: Yan, Junbin, et al.
Publicado: (2021)

Serum FGF21 Levels Predict the MACE in Patients With Myocardial Infarction After Coronary Artery Bypass Graft Surgery
por: Xie, Wei, et al.
Publicado: (2022)

Anti-inflammatory activity of berberine in non-alcoholic fatty liver disease via the Angptl2 pathway
por: Lu, Zengsheng, et al.
Publicado: (2020)

The IDI1/SREBP2 axis drives intrahepatic cholestasis and is a treatment target of San-Huang-Cai-Zhu formula identified by sequencing and experiments
por: Yan, Junbin, et al.
Publicado: (2023)

The Obesity-Related Metabolic Gene HSD17B8 Protects Against Breast Cancer: High RNA/Protein Expression Means a Better Prognosis
por: Nie, Yunmeng, et al.
Publicado: (2022)

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases
por: Cheng, Peng, et al.
Publicado: (2016)

High-Level Serum Fibroblast Growth Factor 21 Concentration Is Closely Associated With an Increased Risk of Cardiovascular Diseases: A Systematic Review and Meta-Analysis
por: Zhang, Yucong, et al.
Publicado: (2021)

Forsythiasides: A review of the pharmacological effects
por: Yang, Hong-Xuan, et al.
Publicado: (2022)

Biological and pharmacological functions of the FGF19- and FGF21-coreceptor beta klotho
por: Aaldijk, Alexandra S., et al.
Publicado: (2023)

Transition of Metabolic Phenotypes and Risk of Atrial Fibrillation According to BMI: Kailuan Study
por: Zhao, Maoxiang, et al.
Publicado: (2022)

Emerging roles of fibroblast growth factor 21 in critical disease
por: Yan, Fang, et al.
Publicado: (2022)

The role of FGF21 and its analogs on liver associated diseases
por: Falamarzi, Kimia, et al.
Publicado: (2022)

Association of Early and Supernormal Vascular Aging categories with cardiovascular disease in the Chinese population
por: Cao, Qiuyu, et al.
Publicado: (2022)

The link between immunity and hypertension in the kidney and heart
por: Benson, Lance N., et al.
Publicado: (2023)

Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis
por: Liu, Cong, et al.
Publicado: (2021)

Arterial Stiffness, Biomarkers of Liver Fat, and the Development of Metabolic Dysfunction in Metabolically Healthy Population: A Prospective Study
por: Lin, Lin, et al.
Publicado: (2022)

Indoxyl sulfate induces left ventricular hypertrophy via the AhR-FGF23-FGFR4 signaling pathway
por: Kishimoto, Hiroshi, et al.
Publicado: (2023)

Non-pharmacological interventions for the prevention of hypertension in low-income and middle-income countries: protocol for a systematic review and meta-analysis
por: Saif-Ur-Rahman, K M, et al.
Publicado: (2018)

Pharmacological interventions for preventing post-operative atrial fibrillation in patients undergoing cardiac surgery: a network meta-analysis protocol
por: Wang, Xiaoqin, et al.
Publicado: (2017)

Perception of pharmacological prevention and subsequent non-adherence to medication in patients with ischaemic heart disease: a population-based cohort study
por: Graversen, Christina Boesgaard, et al.
Publicado: (2022)

Identifying Excessive Intake of Oil and Salt to Prevent and Control Hypertension: A Latent Class Analysis
por: He, Lu, et al.
Publicado: (2022)

Discordance of Apolipoprotein B, Non-HDL-Cholesterol, and LDL-Cholesterol Predicts Risk of Increased Arterial Stiffness and Elevated Carotid Intima-Media Thickness in Middle-Aged and Elderly Chinese Adults
por: Jia, Xiaojing, et al.
Publicado: (2022)

Exploring the Mechanism of Hawthorn Leaves Against Coronary Heart Disease Using Network Pharmacology and Molecular Docking
por: Ding, Jie, et al.
Publicado: (2022)

Short-term changes in klotho and FGF23 in heart failure with reduced ejection fraction—a substudy of the DAPA-VO(2) study
por: Mora-Fernández, Carmen, et al.
Publicado: (2023)

Complications of exercise and pharmacologic stress echocardiography
por: Lee, Christopher, et al.
Publicado: (2023)

Predicting Target Genes of San-Huang-Chai-Zhu Formula in Treating ANIT-Induced Acute Intrahepatic Cholestasis Rat Model via Bioinformatics Analysis Combined with Experimental Validation
por: Yao, Jiaming, et al.
Publicado: (2021)

miR-21 in Human Cardiomyopathies
por: Surina,, et al.
Publicado: (2021)

Aging is associated with increased FGF21 levels but unaltered FGF21 responsiveness in adipose tissue
por: Villarroya, Joan, et al.
Publicado: (2018)

Role of sex on the efficacy of pharmacological and non-pharmacological treatment of heart failure with reduced ejection fraction: A systematic review
por: Sanromán Guerrero, María Ascensión, et al.
Publicado: (2022)

Rheumatoid arthritis and coronary atherosclerosis: a two-sample Mendelian randomization study
por: Nie, Qiong, et al.
Publicado: (2023)

Corrigendum: miR-21 in Human Cardiomyopathies
por: Surina,, et al.
Publicado: (2022)

Fibroblast Growth Factor 21 Predicts Short-Term Prognosis in Patients With Acute Heart Failure: A Prospective Cohort Study
por: Wu, Guihai, et al.
Publicado: (2022)

FGF21 as a Stress Hormone: The Roles of FGF21 in Stress Adaptation and the Treatment of Metabolic Diseases
por: Kim, Kook Hwan, et al.
Publicado: (2014)

Tentative exploration of pharmacodynamic substances: Pharmacological effects, chemical compositions, and multi-components pharmacokinetic characteristics of ESZWD in CHF-HKYd rats
por: Hong, Li-li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bf8f2uqhn4l82vhkiq4ft39ug7